Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?

This article reviews existing data on cytoreduction, evaluating hydroxyurea, interferons, and ruxolitinib in ET and PV. This review evaluates whether evidence supports a more liberal strategy of cytoreduction for all patients with ET and PV. PMID: 30545998 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30545998?dopt=Abstract

Source: Journal of the National Comprehensive Cancer Network : JNCCN - December 15, 2018 Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research